Patents by Inventor YUCHENG MU

YUCHENG MU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE
    Publication number: 20240238258
    Abstract: Disclosed are compounds of Formula (I) pharmaceutically acceptable salts thereof are defined herein, and pharmaceutical compositions thereof and combinations thereof, and methods of using the same as inhibitors of protein tyrosine phosphatases (PTPN2). These compounds are useful in treating cancer and diseases susceptible to PTPN2 inhibition.
    Type: Application
    Filed: December 20, 2023
    Publication date: July 18, 2024
    Applicant: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: HAIBO LIU, YUCHENG MU, ANNAPURNA PENDRI, SHOSHANA L. POSY, JOANNE JEWETT BRONSON, LOUIS S. CHUPAK, LAURA AKULLIAN D'AGOSTINO
  • INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE
    Publication number: 20240228476
    Abstract: Disclosed are compounds of Formula (I) pharmaceutically acceptable salts thereof are defined herein, and pharmaceutical compositions thereof and combinations thereof, and methods of using the same as inhibitors of protein tyrosine phosphatases (PTPN2). These compounds are useful in treating cancer and diseases susceptible to PTPN2 inhibition.
    Type: Application
    Filed: December 20, 2023
    Publication date: July 11, 2024
    Applicant: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: HAIBO LIU, YUCHENG MU, ANNAPURNA PENDRI, SHOSHANA L. POSY, JOANNE JEWETT BRONSON, LOUIS S. CHUPAK, LAURA AKULLIAN D'AGOSTINO
  • INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE
    Publication number: 20240207238
    Abstract: Disclosed are compounds of Formula (I): pharmaceutically acceptable salts thereof are defined herein, and pharmaceutical compositions thereof and combinations thereof, and methods of using the same as inhibitors of protein tyrosine phosphatases (PTPN2). These compounds are useful in treating cancer and diseases susceptible to PTPN2 inhibition.
    Type: Application
    Filed: November 8, 2023
    Publication date: June 27, 2024
    Applicant: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: ANNAPURNA PENDRI, HAIBO LIU, SHOSHANA L. POSY, YUCHENG MU, JOANNE JEWETT BRONSON, LAURA AKULLIAN D'AGOSTINO
  • INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE, COMPOSITIONS, AND METHODS OF USE
    Publication number: 20240180886
    Abstract: Disclosed are compounds of Formula (I) pharmaceutically acceptable salts thereof are defined herein, and pharmaceutical compositions thereof and combinations thereof, and methods of using the same as inhibitors of protein tyrosine phosphatases (PTPN2). These compounds are useful in treating cancer and diseases susceptible to PTPN2 inhibition.
    Type: Application
    Filed: November 8, 2023
    Publication date: June 6, 2024
    Applicant: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: YUCHENG MU, HAIBO LIU, ANNAPURNA PENDRI, SHOSHANA L. POSY, JOANNE JEWETT BRONSON, LAURA AKULLIAN D'AGOSTINO